Pharmacokinetics and milk penetration of difloxacin after a long-acting formulation for subcutaneous administration to lactating goats

Journal of Dairy Science
P MarínC M Carceles

Abstract

The single-dose disposition kinetics of difloxacin were determined in clinically normal lactating goats (n=6) after intravenous (IV) and subcutaneous (SC) administration and subcutaneous administration of a long-acting poloxamer 407 gel formulation (P407). Difloxacin concentrations were determined by HPLC with fluorescence detection. Minimum inhibitory concentrations of difloxacin against 14 strains of Staphylococcus aureus isolated from mastitic goats' milk in Spain were determined to compute pharmacodynamic surrogate markers. The concentration-time data were analyzed by compartmental and noncompartmental pharmacokinetic methods. Following SC and P407 administration, difloxacin achieved maximum milk concentrations of 1.34+/-0.12 and 2.97+/-1.18 mg/L, respectively, at 4.00+/-0.00 h (SC) and 3.60+/-0.89 h (P407) after administration. The absolute bioavailabilities after SC and P407 administration were 81.74+/-15.60% and 72.58+/-20.45%, respectively. Difloxacin penetration from the blood into the milk was good and high concentrations were found in milk secretions. From these data, a 15 mg/kg dose of difloxacin P407 would appear to be effective against Staphylococcus aureus isolated from mastitic goats' milk with minimum inhibitor...Continue Reading

References

Apr 1, 1978·Journal of Pharmacokinetics and Biopharmaceutics·K YamaokaT Uno
Jul 1, 1992·Journal of Pharmaceutical Sciences·E A PecT P Johnston
Jun 1, 1990·Journal of Veterinary Pharmacology and Therapeutics·J Powers
Feb 1, 1990·Clinical Pharmacokinetics·H C Atkinson, E J Begg
Oct 1, 1989·Clinical Microbiology Reviews·J S Wolfson, D C Hooper
Feb 1, 1986·Antimicrobial Agents and Chemotherapy·J M StammP B Fernandes
Nov 1, 1986·Antimicrobial Agents and Chemotherapy·G R GrannemanV S Shu
Nov 1, 1972·Journal of Biomedical Materials Research·I R Schmolka
Jan 1, 1984·Transactions of the Royal Society of Tropical Medicine and Hygiene·E A Llanos CuentasP D Marsden
Oct 1, 1982·Journal of Pharmacokinetics and Biopharmaceutics·K K Chan, M Gibaldi
Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Sep 1, 1996·Journal of Pharmaceutical Sciences·R Bhardwaj, J Blanchard
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·S A Brown
Feb 10, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W A Craig
Jul 23, 1998·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·I KempfM Guittet
Jul 24, 1998·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·H LodeP Koeppe
Jun 26, 1999·The Journal of Antimicrobial Chemotherapy·H M SiefertA Witt
Oct 28, 1999·International Journal of Pharmaceutics·M YunC Kim
May 5, 2000·International Journal of Antimicrobial Agents·F S AliAbadi, P Lees
May 29, 2000·Journal of Veterinary Diagnostic Investigation : Official Publication of the American Association of Veterinary Laboratory Diagnosticians, Inc·R van den HovenR D Walker
Jun 13, 2000·American Journal of Veterinary Research·T W OlchowyR L Herrick
Apr 30, 2002·International Journal of Antimicrobial Agents·Peter Lees, Fariborz Shojaee Aliabadi
Nov 6, 2002·Veterinary Research Communications·A M Abd El-Aty, A Goudah
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lin ZhangUday B Kompella
Apr 23, 2003·Advanced Drug Delivery Reviews·James L McManaman, Margaret C Neville
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, A Bousquet-Mélou
Dec 17, 2004·Journal of Veterinary Pharmacology and Therapeutics·P L Toutain, P Lees
Mar 9, 2005·Veterinary Research Communications·A M Abd El-AtyM Shimoda
Jun 15, 2005·Journal of Veterinary Pharmacology and Therapeutics·V S Mavrogianni, G C Fthenakis
Jun 3, 2006·American Journal of Veterinary Research·Emilio Fernández-VarónIgnacio Ayala
Jul 19, 2006·Journal of Veterinary Pharmacology and Therapeutics·R Gehring, G W Smith
May 13, 2008·Journal of Veterinary Pharmacology and Therapeutics·H Z DingZ L Zeng
Jan 1, 2001·Veterinary Anaesthesia and Analgesia·G F Stegmann, L Bester

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.